Clin2
NCT06405971Possibly a fitRecruiting

Metformin for unruptured brain aneurysms

Dissecting Aneurysm of Cerebral Artery

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests whether the diabetes drug metformin can help prevent unruptured aneurysms in the back part of the brain from growing or causing problems. It is for people whose aneurysms show a specific sign on an MRI scan.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have an unruptured aneurysm in the back part of your brain (vertebrobasilar artery) that has not been treated before.
  • The aneurysm shows a bright spot on a special MRI scan (called aneurysm wall enhancement).
  • You are able to take care of yourself with little or no help (mRS score 0-2).
  • You do not have diabetes, metal implants, or an allergy to MRI contrast dye.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06416657Recruiting
General vs local anesthesia for brain aneurysm treatment

This trial compares general anesthesia (being fully asleep) to local anesthesia (only the area is numbed) during a procedure to treat an unruptured brain aneurysm with a flow diverter. It aims to find which approach is safer and works better.

Beijing, Beijing Municipality
NCT06377696Recruiting· Phase 2
Metformin study for brain tumor survivors after radiation

This study tests whether metformin, a common diabetes medicine, can help protect thinking and memory skills in people who have had radiation for a brain tumor. You will use a smartwatch and take online tests from home to track your progress.

Rochester, Minnesota
NCT06485492Not yet recruiting
Testing a new device to treat brain aneurysms

This trial tests a new device that blocks blood flow into brain aneurysms (balloon-like bulges in blood vessels). It is for patients with a specific type of unruptured or recently ruptured aneurysm, located in three common places in the brain, that has a wide neck.

NCT05576727Not yet recruiting
Using scans to estimate bleeding risk in brain aneurysms

This study looks at how well different scan measurements can predict the chance that an unruptured brain aneurysm may grow or bleed. It may help doctors estimate risk more accurately for people living with an aneurysm that hasn’t ruptured yet.

Hangzhou, Zhejiang
NCT07272967Not yet recruiting· Phase 4
Metformin for preventing scarring after spinal cord injury

This trial tests whether the drug metformin can reduce scarring (gliosis) in the spinal cord after a recent thoraco-lumbar injury. If you've had a spinal cord injury in the past 24 hours and meet the criteria, you may be able to join.

Shibīn al Kawm, Menoufia
NCT06943729Recruiting
Testing a flow-diverter stent for brain aneurysms

This trial tests a flow-diverter stent (a small mesh tube) to treat brain aneurysms that are hard to close with standard methods. It may help if you have a wide-neck or other complex aneurysm that hasn't burst.

Shanghai, Shanghai Municipality

Hear when a new Dissecting Aneurysm of Cerebral Artery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.